CompanyDendreon UK Ltd
ATC codeL03AX17
EU authorised2013-09-06
· 12 yr ago
Flags
—
EMA EPAR
Evidence dossier ↗
Provenge CONFIRMED
autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor (sipuleucel-t) · Prostatic Neoplasms
Current stage: 4 · first detected 2026-06-25
Also known as: provenge
Status timeline
| Date | Body | Status | Stage | Source |
|---|---|---|---|---|
| 2026-06-25 | EMA | withdrawn | 4 | link |